Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Share-based Compensation (2017 - 2025)

Neuronetics (STIM) has disclosed Share-based Compensation for 9 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation fell 0.7% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 0.05% change, with the full-year FY2024 number at $5.6 million, down 23.46% from a year prior.
  • Share-based Compensation was $1.4 million for Q3 2025 at Neuronetics, down from $1.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q1 2022 to a low of $1.3 million in Q4 2024.
  • A 5-year average of $1.8 million and a median of $1.8 million in 2025 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 210.99% in 2021, then decreased 25.87% in 2024.
  • Neuronetics' Share-based Compensation stood at $1.7 million in 2021, then rose by 24.08% to $2.1 million in 2022, then decreased by 23.05% to $1.6 million in 2023, then fell by 21.16% to $1.3 million in 2024, then grew by 9.91% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Share-based Compensation are $1.4 million (Q3 2025), $1.8 million (Q2 2025), and $1.4 million (Q1 2025).